Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA
Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA.
J Neurointerv Surg. 2023 Dec 21;15(e3):e414-e418. doi: 10.1136/jnis-2022-019537.
The safety and efficacy of bridging therapy with intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) in patients with large core infarct has not been sufficiently studied. In this study, we compared the efficacy and safety outcomes between patients who received IVT+MT and those treated with MT alone.
This is a retrospective analysis of the Stroke Thrombectomy Aneurysm Registry (STAR). Patients with Alberta Stroke Program Early CT Score (ASPECTS) ≤5 treated with MT were included in this study. Patients were divided into two groups based on pre-treatment IVT (IVT, no IVT). Propensity score matched analysis were used to compare outcomes between groups.
A total of 398 patients were included; 113 pairs were generated using propensity score matching analyses. Baseline characteristics were well balanced in the matched cohort. The rate of any intracerebral hemorrhage (ICH) was similar between groups in both the full cohort (41.4% vs 42.3%, P=0.85) and matched cohort (38.55% vs 42.1%, P=0.593). Similarly, the rate of significant ICH was similar between the groups (full cohort: 13.1% vs 16.9%, P=0.306; matched cohort: 15.6% vs 18.95, P=0.52). There was no difference in favorable outcome (90-day modified Rankin Scale 0-2) or successful reperfusion between groups. In an adjusted analysis, IVT was not associated with any of the outcomes.
Pretreatment IVT was not associated with an increased risk of hemorrhage in patients with large core infarct treated with MT. Future studies are needed to assess the safety and efficacy of bridging therapy in patients with large core infarct.
静脉溶栓(IVT)和机械取栓(MT)桥接治疗大核心梗死患者的安全性和疗效尚未得到充分研究。在这项研究中,我们比较了接受 IVT+MT 和单独接受 MT 治疗的患者的疗效和安全性结局。
这是对卒中取栓动脉瘤登记研究(STAR)的回顾性分析。本研究纳入了接受 MT 治疗且 Alberta 卒中项目早期 CT 评分(ASPECTS)≤5 的患者。根据治疗前是否接受 IVT(IVT,无 IVT)将患者分为两组。采用倾向评分匹配分析比较两组之间的结局。
共纳入 398 例患者;采用倾向评分匹配分析生成了 113 对。匹配队列中两组的基线特征均衡。全队列(41.4%比 42.3%,P=0.85)和匹配队列(38.55%比 42.1%,P=0.593)中两组的任何颅内出血(ICH)发生率相似。同样,两组之间的严重 ICH 发生率也相似(全队列:13.1%比 16.9%,P=0.306;匹配队列:15.6%比 18.95%,P=0.52)。两组的良好结局(90 天改良Rankin 量表 0-2)或再通成功率无差异。在调整分析中,IVT 与任何结局均无关。
在接受 MT 治疗的大核心梗死患者中,治疗前 IVT 与出血风险增加无关。未来需要研究来评估大核心梗死患者桥接治疗的安全性和疗效。